SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase-Reference-Cited by-同舟云学术

SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase

Published:2008-07 Issue:29 Volume:283 Page:20015-20026
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hou Xiuyun,Xu Shanqin,Maitland-Toolan Karlene A.,Sato Kaori,Jiang Bingbing,Ido Yasuo,Lan Fan,Walsh Kenneth,Wierzbicki Michel,Verbeuren Tony J.,Cohen Richard A.,Zang Mengwei

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference57 articles.

1. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

2. The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

3. The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases

4. AMP-activated protein kinase signaling in metabolic regulation

5. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase

Cited by 692 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT1/AMPK-mediated pathway: Ferulic acid from sugar beet pulp mitigating obesity-induced diabetes-linked complications and improving metabolic health;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2024-10

2. Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications;Human Nutrition & Metabolism;2024-09

3. Disturbance in communication between mitochondrial redox processes and the AMPK/PGC-1α/SIRT-1 axis influences diverse organ symptoms in lupus-affected mice;Mitochondrion;2024-09

4. AMPK activation reduces cancer cell aggressiveness via inhibition of monoamine oxidase A (MAO-A) expression/activity;Life Sciences;2024-09

5. NAD+ metabolism and therapeutic strategies in cardiovascular diseases;Atherosclerosis Plus;2024-09